Search results for " beta 1 subunit"

showing 2 items of 2 documents

Decreased presence of Langerhans cells is a critical determinant for Indian Post kala-azar dermal leishmaniasis.

2015

Post kala-azar dermal leishmaniasis (PKDL) is the dermal sequel of visceral leishmaniasis (VL) and occurs after apparent cure or alongside with VL. It is confined to South Asia (India, Nepal and Bangladesh) and East Africa (mainly Sudan), the incidence being 5-10% and 50-60% respectively. In South Asia, as the transmission of VL is anthroponotic, PKDL patients are the proposed disease reservoir, thus assuming epidemiological significance, its eradication being linked to the control of leishmaniasis. In the absence of an animal model and its low incidence, factors contributing towards the immunopathogenesis of PKDL remain an open-ended, yet pertinent question. This study delineated the lesio…

Disease reservoirIndiaLeishmaniasis CutaneousCell CountDermatologyBiochemistryImmune systemImmunopathologyparasitic diseasesmedicineInterleukin-12 Receptor beta 1 SubunitHumansRNA MessengerMolecular BiologyPost-kala-azar dermal leishmaniasisGranulomabusiness.industryCD68MacrophagesLeishmaniasismedicine.diseaseInterleukin-10Visceral leishmaniasisGranulomaLangerhans CellsImmunologyLeishmaniasis VisceralbusinessExperimental dermatology
researchProduct

The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prol…

1996

Interleukin 6 (IL-6) is considered an important mediator of acute inflammatory responses. Moreover, IL-6 functions as a differentiation and growth factor of hematopoietic precursor cells, B cells, T cells, keratinocytes, neuronal cells, osteoclasts, and endothelial cells. IL-6 exhibits its action via a receptor complex consisting of a specific IL-6 receptor (IL-6R) and a signal transducing subunit (gp130). Soluble forms of both receptor components are generated by shedding and are found in patients with various diseases such as acquired immune deficiency syndrome, rheumatoid arthritis, and others. The function of the soluble (s)IL-6R in vivo is unknown. Since human (h)IL-6 acts on human and…

Receptor complexImmunologyMice TransgenicInterleukin 1 receptor type IIBiologyMiceSpecies SpecificityAntigens CDInterleukin-4 receptorImmunology and AllergyAnimalsHumansAcute-Phase ReactionInterleukin 12 receptor beta 1 subunitInterleukin 3HaptoglobinsInterleukin-6Receptors InterleukinArticlesMolecular biologyReceptors Interleukin-6Interleukin 10LiverSolubilityInterleukin-6 receptorPhosphoenolpyruvate Carboxykinase (GTP)Interleukin 1 receptor type ICarrier ProteinsHalf-LifeThe Journal of experimental medicine
researchProduct